estriol has been researched along with Disease Models, Animal in 16 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the use of estriol in the treatment of experimental autoimmune encephalomyelitis (EAE) and other cell mediated autoimmune diseases." | 7.70 | Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. ( Dalal, MA; Kim, S; Liva, SM; Verity, MA; Voskuhl, RR, 1999) |
| "To evaluate the use of estriol in the treatment of experimental autoimmune encephalomyelitis (EAE) and other cell mediated autoimmune diseases." | 3.70 | Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. ( Dalal, MA; Kim, S; Liva, SM; Verity, MA; Voskuhl, RR, 1999) |
| "Currently, the cause of MS is unknown." | 2.48 | Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. ( Spence, RD; Voskuhl, RR, 2012) |
| "Formononetin increase the uterus coefficient and the expression of atrial ERbeta (P < 0." | 1.36 | [The estrogenic effect of formononetin and its effect on the expression of rats' atrium estrogen receptors]. ( Huang, Q; Liu, XL; Liu, ZG; Xing, DX; Xiong, L; Xue, CK, 2010) |
| "Oestriol treatment had no effect on dopaminergic markers in MPTP mice whereas oestrone prevented striatal DAT loss and the decrease of VMAT2 mRNA in the substantia nigra." | 1.33 | Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. ( Di Paolo, T; Jourdain, S; Morin, N; Morissette, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Zhu, H | 1 |
| Zhang, W | 1 |
| Zhao, Y | 1 |
| Shu, X | 1 |
| Wang, W | 1 |
| Wang, D | 1 |
| Yang, Y | 1 |
| He, Z | 1 |
| Wang, X | 1 |
| Ying, Y | 1 |
| Ahmad, A | 1 |
| Vohora, D | 1 |
| Sliwiński, L | 1 |
| Folwarczna, J | 1 |
| Nowińska, B | 1 |
| Cegieła, U | 1 |
| Pytlik, M | 1 |
| Kaczmarczyk-Sedlak, I | 1 |
| Trzeciak, H | 1 |
| Trzeciak, HI | 1 |
| Ploumidou, K | 1 |
| Kyroudi-Voulgari, A | 1 |
| Perea, D | 1 |
| Anastasiou, I | 1 |
| Mitropoulos, D | 1 |
| Xing, DX | 1 |
| Liu, XL | 1 |
| Xue, CK | 1 |
| Huang, Q | 1 |
| Liu, ZG | 1 |
| Xiong, L | 1 |
| Spence, RD | 1 |
| Voskuhl, RR | 3 |
| Miao, Q | 1 |
| Li, JG | 1 |
| Miao, S | 1 |
| Hu, N | 1 |
| Zhang, J | 1 |
| Zhang, S | 1 |
| Xie, YH | 1 |
| Wang, JB | 1 |
| Wang, SW | 1 |
| Palaszynski, KM | 1 |
| Liu, H | 1 |
| Loo, KK | 1 |
| Jourdain, S | 1 |
| Morissette, M | 1 |
| Morin, N | 1 |
| Di Paolo, T | 1 |
| Ding, J | 1 |
| Zhu, BT | 1 |
| Psychoyos, A | 1 |
| Nikas, G | 1 |
| Sarantis, L | 1 |
| Gravanis, A | 1 |
| Kim, S | 1 |
| Liva, SM | 1 |
| Dalal, MA | 1 |
| Verity, MA | 1 |
| Sandberg, AA | 1 |
| Lopez del Pino, V | 1 |
| Bolt, HM | 1 |
| Ezaki, T | 1 |
| Fujii, H | 1 |
| Matsuno, K | 1 |
| Kawatsu, R | 1 |
| Kotani, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Trial of Testosterone Treatment for Fatigue in Men With Multiple Sclerosis[NCT03000127] | Phase 2 | 0 participants (Actual) | Interventional | 2018-07-01 | Withdrawn (stopped due to Lack of funding) | ||
| Safety and Tolerability of Oral Two-Doses Estroprogestins Associated With Interferon-Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis[NCT00151801] | Phase 2 | 200 participants | Interventional | 2002-05-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for estriol and Disease Models, Animal
| Article | Year |
|---|---|
Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration.
Topics: Animals; Central Nervous System Diseases; Dihydrotestosterone; Disease Models, Animal; Encephalomyel | 2012 |
Potential test systems for chemotherapeutic agents against prostatic cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Animals; Antineoplastic Agents; Arginase; Dihydrot | 1975 |
14 other studies available for estriol and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Estriol; Evoked Potentials, Visual; Glycogen Syn | 2018 |
Proconvulsant effects of estriol, the third estrogen, in the mouse PTZ-kindling model.
Topics: Animals; Anticonvulsants; Clomiphene; Convulsants; Diazepam; Disease Models, Animal; Estriol; Female | 2014 |
A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
Topics: Animals; Body Weight; Bone and Bones; Bone Density; Bone Marrow Cells; Bone Resorption; Calcificatio | 2009 |
Effect of a hypercholesterolemic diet on serum lipid profile, plasma sex steroid levels, and prostate structure in rats.
Topics: Animals; Cholesterol; Cholesterol, Dietary; Cholic Acid; Disease Models, Animal; Epithelial Cells; E | 2010 |
[The estrogenic effect of formononetin and its effect on the expression of rats' atrium estrogen receptors].
Topics: Administration, Oral; Animals; Disease Models, Animal; Estriol; Estrogen Receptor alpha; Estrogen Re | 2010 |
The bone-protective effect of genistein in the animal model of bilateral ovariectomy: roles of phytoestrogens and PTH/PTHR1 against post-menopausal osteoporosis.
Topics: Alkaline Phosphatase; Animals; Bone Density; Creatinine; Disease Models, Animal; Estriol; Female; Fe | 2012 |
Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Topics: Analysis of Variance; Animals; Cell Culture Techniques; Cytokines; Disease Models, Animal; Encephalo | 2004 |
Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Topics: Animals; Disease Models, Animal; Dopamine; Estradiol; Estriol; Estrogens; Estrone; Injections, Intra | 2005 |
Unique effect of the pregnancy hormone estriol on antigen-induced production of specific antibodies in female BALB/c mice.
Topics: Animals; Antibodies; Antibody Formation; Antibody Specificity; Antigens; B-Lymphocytes; Bacterial Ca | 2008 |
Hormonal anti-implantation agents: antiprogestins.
Topics: Animals; Contraceptives, Postcoital, Synthetic; Disease Models, Animal; Dose-Response Relationship, | 1995 |
Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis.
Topics: Animals; Autoimmune Diseases; Brain; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experime | 1999 |
[The thioacetamide-poisoned rat as an animal experimental model for endocrinological studies of estrogen metabolism in chronic liver injury)].
Topics: Acetamides; Aminopyrine N-Demethylase; Aniline Hydroxylase; Animals; Chemical and Drug Induced Liver | 1975 |
Oestrogen retards the development of spontaneous thymomas in BUF/Mna rats.
Topics: Age Factors; Animals; Body Weight; Castration; Disease Models, Animal; Estriol; Female; Male; Ovarie | 1992 |